Search research articles
Contact Us
Filters
Showing results (81-90 of 1,365) with videos related to
Page
of 137
Sort By:
Drug Development Research
|
November 27, 2021
Antiproliferative, antimigratory, and prooxidative potential of novel platinum(IV) complexes and resveratrol on breast cancer (MDA-MB-231) and choriocarcinoma (JEG-3) cell lines
Milica G Paunović, Miloš M Matić, Ana D Obradović, et al.
Drug Development Research
|
December 3, 2021
Sinapic acid inhibits pancreatic cancer proliferation, migration, and invasion via downregulation of the AKT/Gsk-3β signal pathway
Zhiwei Huang, Hao Chen, Peng Tan, et al.
Drug Development Research
|
November 3, 2021
A comparative study of the in vitro antitumor effect of mannose-doxorubicin conjugates with different linkers
Xinxin Cui, Kunda Du, Xiaoyin Yuan, et al.
Drug Development Research
|
January 26, 2021
Targeting cyclooxygenase enzyme for the adjuvant COVID-19 therapy
Parteek Prasher, Mousmee Sharma, Ravi Gunupuru
Drug Development Research
|
May 1, 2014
Optimized nonclinical safety assessment strategies supporting clinical development of therapeutic monoclonal antibodies targeting inflammatory diseases
Frank R Brennan, Annick Cauvin, Jay Tibbitts, et al.
Drug Development Research
|
February 9, 2017
Antinociceptive and Antihyperalgesic Activity of a Traditional Maya Herbal Preparation Composed of Pouteria Campechiana, Chrysophyllum Cainito, Citrus Limonum, and Annona Muricata
Myrna Déciga-Campos, Rolffy Ortiz-Andrade, Amanda Sanchez-Recillas, et al.
Drug Development Research
|
February 15, 2017
NS1209/SPD 502, A Novel Selective AMPA Antagonist for Stroke, Neuropathic Pain or Epilepsy? Drug Development Lessons Learned
Jan M Keppel Hesselink
Drug Development Research
|
November 29, 2021
Sodium tanshinone IIA sulfonate promotes spinal cord injury repair by inhibiting blood spinal cord barrier disruption in vitro and in vivo
Dan Luo, Xing Li, Yonghui Hou, et al.
Drug Development Research
|
March 4, 2021
Contribution of N-heterocycles towards anti-tubercular drug discovery (2014-2019); predicted and reengineered molecular frameworks
Dorababu Atukuri, Rutu Gunjal, Nagaraj Holagundi, et al.
Drug Development Research
|
September 1, 2019
Artesunate suppresses inflammation and oxidative stress in a rat model of colorectal cancer
Vijay L Kumar, Sneh Verma, Prasenjit Das
Page
of 137
Search research articles
Search
Showing results (81-90 of 1,365) with videos related to
Sort By:
Page
of 137
Drug Development Research
|
November 27, 2021
Antiproliferative, antimigratory, and prooxidative potential of novel platinum(IV) complexes and resveratrol on breast cancer (MDA-MB-231) and choriocarcinoma (JEG-3) cell lines
Milica G Paunović, Miloš M Matić, Ana D Obradović, et al.
Drug Development Research
|
December 3, 2021
Sinapic acid inhibits pancreatic cancer proliferation, migration, and invasion via downregulation of the AKT/Gsk-3β signal pathway
Zhiwei Huang, Hao Chen, Peng Tan, et al.
Drug Development Research
|
November 3, 2021
A comparative study of the in vitro antitumor effect of mannose-doxorubicin conjugates with different linkers
Xinxin Cui, Kunda Du, Xiaoyin Yuan, et al.
Drug Development Research
|
January 26, 2021
Targeting cyclooxygenase enzyme for the adjuvant COVID-19 therapy
Parteek Prasher, Mousmee Sharma, Ravi Gunupuru
Drug Development Research
|
May 1, 2014
Optimized nonclinical safety assessment strategies supporting clinical development of therapeutic monoclonal antibodies targeting inflammatory diseases
Frank R Brennan, Annick Cauvin, Jay Tibbitts, et al.
Drug Development Research
|
February 9, 2017
Antinociceptive and Antihyperalgesic Activity of a Traditional Maya Herbal Preparation Composed of Pouteria Campechiana, Chrysophyllum Cainito, Citrus Limonum, and Annona Muricata
Myrna Déciga-Campos, Rolffy Ortiz-Andrade, Amanda Sanchez-Recillas, et al.
Drug Development Research
|
February 15, 2017
NS1209/SPD 502, A Novel Selective AMPA Antagonist for Stroke, Neuropathic Pain or Epilepsy? Drug Development Lessons Learned
Jan M Keppel Hesselink
Drug Development Research
|
November 29, 2021
Sodium tanshinone IIA sulfonate promotes spinal cord injury repair by inhibiting blood spinal cord barrier disruption in vitro and in vivo
Dan Luo, Xing Li, Yonghui Hou, et al.
Drug Development Research
|
March 4, 2021
Contribution of N-heterocycles towards anti-tubercular drug discovery (2014-2019); predicted and reengineered molecular frameworks
Dorababu Atukuri, Rutu Gunjal, Nagaraj Holagundi, et al.
Drug Development Research
|
September 1, 2019
Artesunate suppresses inflammation and oxidative stress in a rat model of colorectal cancer
Vijay L Kumar, Sneh Verma, Prasenjit Das
Page
of 137